| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,918 |
2,876 |
$1.05M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,203 |
16,571 |
$785K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,510 |
14,767 |
$744K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,993 |
2,957 |
$216K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,771 |
2,754 |
$188K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,159 |
2,148 |
$166K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,714 |
2,698 |
$151K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,563 |
1,554 |
$128K |
| 92551 |
|
7,754 |
7,702 |
$105K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,801 |
1,720 |
$63K |
| G9920 |
Screening performed and negative |
1,135 |
1,125 |
$40K |
| 99173 |
|
6,269 |
6,225 |
$30K |
| 99383 |
|
354 |
353 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,274 |
1,176 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
821 |
790 |
$20K |
| 85018 |
|
11,352 |
11,016 |
$18K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
314 |
311 |
$14K |
| 99384 |
|
190 |
188 |
$14K |
| 99382 |
|
235 |
235 |
$12K |
| 90670 |
|
1,089 |
1,075 |
$12K |
| 83655 |
|
1,317 |
1,303 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
148 |
148 |
$11K |
| 90658 |
|
1,001 |
997 |
$11K |
| 90633 |
|
876 |
870 |
$10K |
| 90649 |
|
344 |
343 |
$6K |
| 90710 |
|
508 |
506 |
$6K |
| 90698 |
|
430 |
427 |
$5K |
| 99385 |
|
36 |
36 |
$4K |
| 81003 |
|
2,534 |
2,455 |
$4K |
| 90734 |
|
350 |
348 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
697 |
688 |
$4K |
| 87428 |
|
57 |
55 |
$4K |
| 90696 |
|
319 |
318 |
$3K |
| 87400 |
|
565 |
288 |
$3K |
| 96127 |
|
521 |
521 |
$3K |
| 90715 |
|
251 |
249 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
154 |
149 |
$3K |
| 90744 |
|
233 |
232 |
$3K |
| 90651 |
|
221 |
221 |
$2K |
| 86580 |
|
810 |
663 |
$2K |
| 86328 |
|
42 |
40 |
$2K |
| 90700 |
|
162 |
162 |
$2K |
| 90647 |
|
154 |
152 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
13 |
$2K |
| 99381 |
|
38 |
38 |
$2K |
| 90716 |
|
138 |
138 |
$2K |
| 90655 |
|
133 |
133 |
$1K |
| 93000 |
|
38 |
38 |
$1K |
| 90619 |
|
119 |
119 |
$1K |
| 90707 |
|
109 |
108 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
30 |
30 |
$1K |
| 90680 |
|
101 |
100 |
$1K |
| 99188 |
|
27 |
27 |
$583.20 |
| 90674 |
|
33 |
33 |
$356.40 |
| 90656 |
|
15 |
15 |
$162.00 |
| 90661 |
|
14 |
14 |
$151.20 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,335 |
1,330 |
$150.00 |
| 90681 |
|
13 |
13 |
$144.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
967 |
894 |
$42.39 |
| 99000 |
|
16 |
15 |
$0.00 |
| 81099 |
|
145 |
140 |
$0.00 |
| 3725F |
|
361 |
360 |
$0.00 |